Dr. Ronald Carter
For Biotechs  ·  Fractional CMO & Clinical Development Advisory

Senior clinical leadership, without a full-time CMO.

I help early-stage biotechs design, de-risk and defend their clinical programs, from first-in-human to pivotal Phase III. I bring four Chief Medical Officer roles in oncology and immunology, more than 25 years in drug development, and the judgment boards and investors expect.
Who it's for
Strong science, and a clinical program
that is about to get expensive.

Most of my clients are small teams with strong science and a clinical program that is about to get expensive.

Therapeutic focus: oncology, immunology and inflammation, and microbiome-based therapies.

What I do
The medical leadership a CMO would own,
scoped to your stage.

I take on the medical leadership work a CMO would own, scoped to what your stage actually needs.

How I work
AI by your choice.

It's one service with one standard of judgment. You decide, at the start of each engagement, whether AI tools may be used on your data.

With AI · recommended for most programs

My preferred tool is Claude, Anthropic's AI model. I use it inside dedicated, sandboxed workspaces set up separately for each client and program. It takes on the labor-intensive parts of the work: literature and landscape synthesis, first drafts of protocols and briefing documents, and consistency checks across documents. You get the same senior review in less time and at lower cost. I verify, edit and sign off every output personally. AI drafts; I decide.

Without AI

For programs where your policies, partners or the sensitivity of the data rule it out, I work entirely by hand. The scope and quality are the same; timelines and fees reflect the extra hours.

Either way
Your data stays within your program's own workspace and is never mixed with another client's work.
Your confidential data is never used to train AI models.
You can change the setting at any time, for the whole engagement or for specific documents.
Every deliverable carries my professional responsibility, not a tool's.
Engagement models
Four ways to work together.

From a single expert session to ongoing leadership. Each one starts with a short scoping call.

ModelBest forCommitment
Fractional CMOOngoing medical leadership through a development phaseSet days per month, over several months
ProjectA defined deliverable: clinical development plan, protocol, regulatory package, advisory boardFixed scope and timeline
Expert interventionOne focused question: a protocol or synopsis review, a regulatory meeting rehearsal, a second opinion on trial design or a safety signalA few hours to a few days
Advisory and diligenceBoard support, investor due diligence, scientific advisory boardsHourly or short retainer

Every engagement can be delivered with or without AI. Fees are quoted in the proposal.

Background
More than 25 years in drug development,
on the sponsor side and in clinical practice.
Selected outcomes

Network. Over the years I've built a working network of key opinion leaders in the US and Europe in oncology (melanoma, GvHD, colorectal, lung and kidney cancer) and inflammatory bowel disease (ulcerative colitis), along with specialists in AI implementation for the pharmaceutical industry. Clients can draw on it for advisory boards, investigator recruitment and independent second opinions.

FAQ
Common questions.
How quickly can you start?
Usually within two to three weeks of a signed proposal. Diligence reviews can often start sooner.
Do you work with our CRO and existing team?
Yes. I work alongside your CRO, regulatory consultants and scientists, and I don't duplicate what they already do well.
Which AI tools do you use, and where does your data go?
My preferred tool is Claude, by Anthropic. Each client and program gets its own dedicated, sandboxed project workspace, so your documents are never mixed with another client's. I work only under terms that exclude training on client data, and your proposal sets out the data-handling terms before any work starts.
Can you sign as medical monitor or sit on our board?
That depends on scope, conflicts and jurisdiction. We'll discuss it during scoping.
Where are you based?
I'm based in San Francisco and Lima, and I work on US business hours, with good morning overlap with Europe. My Latin American base is an advantage when a program needs trial sites, investigators or regulatory strategy in the region, and I work natively in Spanish as well as English and German.
Contact
Let's look at your program together.

Tell me where you are and what's next. I'll reply within two business days to set up a 30-minute call, with no obligation. Or book a slot directly.

Choose a time for a 30-minute introductory call.

Book a 30-minute intro call
Prefer a plain link? Open the booking page
Availability
US business hours, with good morning overlap with Europe (UTC−5).

Please don't include confidential program details in this message. We'll agree on terms before you share them.